Research and data on medical cannabis


Read time: 6 minutes

This article highlights key research areas, statewide data, and ongoing efforts to improve patient outcomes.

Why research matters

Research helps improve medical cannabis treatments, supports safety, and guides policy decisions. Data also helps identify trends in access and patient outcomes.

Opioid and alcohol data in Connecticut

Connecticut continues to see high rates of opioid‑related deaths and alcohol‑impaired driving. These trends help inform discussions about harm reduction and patient needs.

Product safety and testing

We monitor issues related to product remediation, testing, and labeling. Patients benefit from clear information about how products are made and tested.

Patient outcomes and feedback

Patient stories help identify gaps in care, challenges with certification, and concerns about product access. This information supports research and helps improve the medical program.

Collaboration with agencies and states

We work with Connecticut agencies, federal partners, and other states to share data, understand national trends, and strengthen patient protections.

How the Cannabis Ombudsman helps

We track patient outcomes. We review safety and access data. We encourage clear labeling and testing. We share information with policymakers. We support research that benefits patients.

 

Research and data